Investment enables development of revolutionary multi-omic platform using super-resolution imaging technology for earlier disease detection and accelerated discovery of therapeutics
The company has reported total income of Rs. 815.11 crores during the period ended March 31, 2023
The news on a shift in its focus comes after the refinement of Bayer’s early innovation framework
To create leading company developing medicines targeting metalloenzymes
All claims against the company in the litigation have now been dismissed.
The current ruling will assure the safety of the use of Ranitidine for Indian patients
He is a seasoned business leader with a successful track record of over 26 years across local and area roles within the pharmaceutical industry
GlaxoSmithKline Pharmaceuticals has reported total income of Rs. 772.71 crores during the period ended June 30, 2022
The proposed combination involves corporate restructuring of JVCO, including through acquisition by Haleon via demerger
Co-marketing agreement between Thermo Fisher Scientific and TransMIT allows for high spatial and high mass resolution MSI platform to study complex biological tissues
Subscribe To Our Newsletter & Stay Updated
